Skip to main content
Fig. 4 | Lipids in Health and Disease

Fig. 4

From: Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway

Fig. 4

Inhibition of FASN suppresses the proliferation of NSCLC cells. Cell viability assays were conducted 1–5 days after RNAi transfection. Compared with the blank and control groups, the proliferation of experimental group A549 cells was significantly lower at the fifth day post-transfection (a); and experimental group NCI-H1299 cells were significantly lower 4 days post-transfection (b). * P < 0.05, ** P < 0.01: compared to the control group. # P < 0.05, ## P < 0.01: compared to the blank group

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X